IsoPlexis Investor Relations Material
Latest events
Status Update
IsoPlexis
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from IsoPlexis Corporation
Access all reports
IsoPlexis Corporation is a life sciences company that develops single-cell analysis solutions to advance precision medicine and immunology research. The company’s technology platform allows researchers to analyze the functional proteomics of individual cells, providing insights into immune system responses and disease progression. The company is headquartered in Branford, Connecticut, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
ISO
Country
🇺🇸 United States